RxDoctor Payments Data

Amy Munro, PA

Physician Assistant · Cheektowaga, NYNPI 1366447765

Payments from drug & device makers

$18,359in general payments, 2019–2025

Across 1,013 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$2K
  • AbbVie$2K
  • Amgen$1K
  • GSK$1K
  • plus $8K from 37 others

What the payments were for

  • Food & beverage$18,336100%
  • Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,359 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$36,730
Medicare patients
70
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide238$295,957
Trelegy ElliptaFluticasone/Umeclidin/Vilanter145$104,909
MounjaroTirzepatide93$95,622
EliquisApixaban106$82,376
TrulicityDulaglutide28$60,386
FarxigaDapagliflozin Propanediol43$59,602
JardianceEmpagliflozin55$56,094
XareltoRivaroxaban30$48,407
VascepaIcosapent Ethyl64$47,115
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr79$44,376
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$26,929
RybelsusSemaglutide13$22,914
Repatha SureclickEvolocumab27$22,508
Icosapent Ethyl41$19,001
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$13,939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,125$318,871251 claims
Lilly USA, LLCMounjaro, Trulicity$1,751$156,008121 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$1,273$154,765236 claims
PfizerEliquis, Lyrica$213$92,231117 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$1,863$91,22787 claims
Boehringer IngelheimJardiance$494$56,09455 claims
Johnson & JohnsonXarelto$86$48,40730 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$290$13,43713 claims
Astellas Pharma US IncMyrbetriq$482$10,96311 claims
AbbVieSynthroid$1,710$4,99466 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Cheektowaga

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →